The Drug Of Medical Marijuana

983 Words Jun 26th, 2015 4 Pages
The FDA has an obvious bias against medical marijuana. The agency would relinquish a tremendous amount of bureaucratic power if it acknowledged the medicinal benefits of marijuana. Simply put, a plant can’t be patented, but the isolated compounds within it can be. Likewise, drug companies would obviously prefer a system in which consumers face potential jail time for marijuana and forced to pay sky high prices from prescription drugs which synthesize marijuana’s chemicals.
There is also revolving door between employees of drug companies and the FDA, another obvious conflict of interest. However, there are larger systematic conflicts of interest within the FDA. In 1992, Congress passed the Prescription Drug User Fee Act allowing drug companies to pay “user fees” to the FDA in order to speed up the approval process. In 2006 alone, those fees added up to $300 million. In essence, that puts the FDA on the payroll of drug companies. As a result, the negative side effects from various drugs are frequently repressed from the public, even after they have been on the market.
Pharmacy retailers once sued Pfizer for allegedly conspiring with generic drug manufacturers to delay the launch of their cheaper generic drugs. However, the FDA’s “user fees” systematically generated similar results. Consumers were punished routinely with higher priced prescription drugs because generic drug companies couldn’t pay “user fees” until 2012. Consequently, the approval process generally took…
Open Document